|
1
|
Kassam Z, Mackay H, Buckley CA, Fung S,
Pintile M, Kim J and Ringash J: Evaluating the impact on quality of
life of chemoradiation in gastric cancer. Curr Oncol. 17:77–84.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen XZ, Zhang WH and Hu JK: A difficulty
in improving population survival outcome of gastric cancer in
mainland China: Low proportion of early diseases. Med Oncol.
31:3152014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ye L, Zhang ZY, Du WD, Schneider ME, Qiu
Y, Zhou Y, Zhou FS, Zuo XB, Chen G, Ma XL, et al: Genetic analysis
of ADIPOQ variants and gastric cancer risk: A hospital-based
case-control study in China. Med Oncol. 30:6582013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fock KM: Review article: The epidemiology
and prevention of gastric cancer. Aliment Pharmacol Ther.
40:250–260. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Soulié P, Bensmaïne A, Garrino C, Chollet
P, Brain E, Fereres M, Jasmin C, Musset M, Misset JL and Cvitkovic
E: Oxaliplatin/cisplatin (L-OHP/CDDP) combination in heavily
pretreated ovarian cancer. Eur J Cancer. 33:1400–1406. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dong HL and Chen M: GEM combination
5-Fu/L-OHP treatment of advanced pancreatic cancer, effect
observation of 47 cases. Mod Prev Med. 35:3872–3873. 2008.
|
|
8
|
Zhang C, Ren Z and Li C: Recent effect of
combination chemotherapy of hydroxycamptothecin and 5-FU, MMC for
advanced pancreatic cancer. Guangzhou Med J. 34:38–39. 2003.
|
|
9
|
Rebucci M and Michiels C: Molecular
aspects of cancer cell resistance to chemotherapy. Biochem
Pharmacol. 85:1219–1226. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cervantes A, Roselló S, Roda D and
Rodríguez-Braun E: The treatment of advanced gastric cancer:
Current strategies and future perspectives. Ann Oncol. 19 Suppl
5:v103–v107. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yoong J, Michael M and Leong T: Targeted
therapies for gastric cancer: Current status. Drugs. 71:1367–1384.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mathé G, Kidani Y, Noji M, Maral R, Bourut
C and Chenu E: Antitumor activity of l-OHP in mice. Cancer Lett.
27:135–143. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Degardin M, Cappelaere P, Krakowski I,
Fargeot P, Cupissol D and Brienza S: Phase II trial of oxaliplatin
(L-OHP) in advanced, recurrent and/or metastatic squamous cell
carcinoma of the head and neck. Eur J Cancer B Oral Oncol.
32B:278–279. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fiteni F, Nguyen T, Vernerey D, Paillard
MJ, Kim S, Demarchi M, Fein F, Borg C, Bonnetain F and Pivot X:
Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment
of advanced biliary tract cancer: A systematic review. Cancer Med.
3:1502–1511. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang C, Jia S and Su X: Effect of
anticancer bioactive peptide on the gene expression of human
gastric cancer BGC-823 cells. J Clin Oncol. 37:1021–1023. 2010.
|
|
16
|
Wen ZH and Su XL: The effect of
anti-cancer bioactive peptide on the expression of p53 and Bcl-2 of
tumor tissues of experimental nude mice. Med Rev. 17:1557–1559.
2011.
|
|
17
|
Su X, Dong C, Zhang J, Su L, Wang X, Cui H
and Chen Z: Combination therapy of anti-cancer bioactive peptide
with Cisplatin decreases chemotherapy dosing and toxicity to
improve the quality of life in xenograft nude mice bearing human
gastric cancer. Cell Biosci. 4:72014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sui CG, Meng FD, Li Y and Jiang YH:
Antiproliferative activity of rosamultic acid is associated with
induction of apoptosis, cell cycle arrest, inhibition of cell
migration and caspase activation in human gastric cancer (SGC-7901)
cells. Phytomedicine. 22:796–806. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−ΔΔC(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tu K, Zheng X, Zhou Z, Li C, Zhang J, Gao
J, Yao Y and Liu Q: Recombinant human adenovirus-p53 injection
induced apoptosis in hepatocellular carcinoma cell lines mediated
by p53-Fbxw7 pathway, which controls c-Myc and cyclin E. PLoS One.
8:e685742013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yao HJ, Zhang YG, Sun L and Liu Y: The
effect of hyaluronic acid functionalized carbon nanotubes loaded
with salinomycin on gastric cancer stem cells. Biomaterials.
35:9208–9223. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang J, Chen X, Su L, Li P, Cai Q, Liu B,
Wu W and Zhu Z: MicroRNA-126 inhibits cell proliferation in gastric
cancer by targeting LAT-1. Biomed Pharmacother. 72:66–73. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tu K, Zheng X, Zan X, Han S, Yao Y and Liu
Q: Evaluation of Fbxw7 expression and its correlation with the
expression of c-Myc, cyclin E and p53 in human hepatocellular
carcinoma. Hepatol Res. 42:904–910. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yin T, Lu L, Xiong Z, Wei S and Cui D:
ATPase inhibitory factor 1 is a prognostic marker and contributes
to proliferation and invasion of human gastric cancer cells. Biomed
Pharmacother. 70:90–96. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Stacul F, Bertolotto M, De Gobbis F,
Calderan L, Cioffi V, Romano A, Zanconati F and Cova MA: US,
colour-Doppler US and fine-needle aspiration biopsy in the
diagnosis of thyroid nodules. Radiol Med (Torino). 112:751–762.
2007. View Article : Google Scholar
|
|
26
|
Yu L, Yang L, An W and Su X: Anticancer
bioactive peptide-3 inhibits human gastric cancer growth by
suppressing gastric cancer stem cells. J Cell Biochem. 115:697–711.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Su L, Xu G, Shen J, Tuo Y, Zhang X, Jia S,
Chen Z and Su X: Anticancer bioactive peptide suppresses human
gastric cancer growth through modulation of apoptosis and the cell
cycle. Oncol Rep. 23:3–9. 2010.PubMed/NCBI
|
|
28
|
Kundu T, Dey S, Roy M, Siddiqi M and
Bhattacharya RK: Induction of apoptosis in human leukemia cells by
black tea and its polyphenol theaflavin. Cancer Lett. 230:111–121.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Alshatwi AA, Athinarayanan J and Periasamy
VS: Green synthesis of bimetallic Au@Pt nanostructures and their
application for proliferation inhibition and apoptosis induction in
human cervical cancer cell. J Mater Sci Mater Med. 26:1482015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Khoo BY, Chua SL and Balaram P: Apoptotic
effects of chrysin in human cancer cell lines. Int J Mol Sci.
11:2188–2199. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li W, Wang J, Jiang HR, Xu XL, Zhang J,
Liu ML and Zhai LY: Combined effects of cyclooxygenase-1 and
cyclooxygenase-2 selective inhibitors on ovarian carcinoma in vivo.
Int J Mol Sci. 12:668–681. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pietenpol JA and Stewart ZA: Cell cycle
checkpoint signaling: Cell cycle arrest versus apoptosis.
Toxicology. 181–182. 2002.PubMed/NCBI
|
|
33
|
Xiang Z, Kang QJ and Xiang X: Gene and
protein expression in the oxaliplatin-resistant HT29/L-OHP human
colon cancer cell line. Genet Mol Res. 14:11013–11022. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Reubold TF and Eschenburg S: A molecular
view on signal transduction by the apoptosome. Cell Signal.
24:1420–1425. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Huang L, Zhang T, Li S, Duan J, Ye F, Li
H, She Z, Gao G and Yang X: Anthraquinone G503 induces apoptosis in
gastric cancer cells through the mitochondrial pathway. PLoS One.
9:e1082862014. View Article : Google Scholar : PubMed/NCBI
|
